Ever Supreme Bio Technology Co., Ltd (TPEX:6712)

TPEX:6712 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	138.94	301.68	336.44	353.57	641.1	68.88
Short-Term Investments	144.5	636.5	998.6	915.99	702.6	346.1
Cash & Short-Term Investments	283.44	938.18	1,335	1,270	1,344	414.98
Cash Growth	-56.38%	-29.73%	5.16%	-5.52%	223.80%	-30.15%
Accounts Receivable	101.14	193.99	100.63	84.94	33.66	15.4
Other Receivables	19.88	7.56	0.46	0.88	29.6	2.24
Receivables	121.02	201.54	101.09	85.82	63.27	17.63
Inventory	105.19	80.04	69.09	88.3	56.77	35.49
Prepaid Expenses	2.81	3.44	7.92	6.29	2.11	10.46
Other Current Assets	1.9	0.06	7.73	5.46	0.92	0.07
Total Current Assets	514.36	1,223	1,521	1,455	1,467	478.63
Property, Plant & Equipment	84.61	48.58	64.81	89.84	125.01	171.24
Long-Term Investments	994.72	796.16	471.31	376.37	333.27	112.51
Other Intangible Assets	13.94	10.15	10.65	11.95	11.14	9.9
Long-Term Deferred Tax Assets	11.01	10.73	1.71	30.32	78.2	80.56
Other Long-Term Assets	47.1	47.24	6.57	9.72	8.22	5.48
Total Assets	1,666	2,136	2,076	1,974	2,023	858.32
Accounts Payable	37.94	25.13	23.33	29.08	15	5.04
Accrued Expenses	-	2.4	1.96	3.98	10.49	3.62
Current Portion of Leases	10.52	1.71	5.4	4.5	11.87	9.87
Current Income Taxes Payable	38.06	68.07	46.76	10.47	21.04	-
Current Unearned Revenue	248.18	194.13	121.65	89.89	12.22	4.12
Other Current Liabilities	30.42	37.66	32.55	25.82	25.9	17.67
Total Current Liabilities	365.12	329.09	231.64	163.74	96.51	40.32
Long-Term Leases	33.58	1.14	0.5	13.36	22.55	33.34
Long-Term Deferred Tax Liabilities	8.19	10.82	-	3.59	3.82	0.05
Other Long-Term Liabilities	18.38	0.78	0.82	0.76	1.96	3.86
Total Liabilities	425.27	341.82	232.96	181.45	124.83	77.56
Common Stock	875.97	806.73	733.39	681.4	618.18	562.89
Additional Paid-In Capital	509.31	551.72	785.91	872.22	1,211	486.55
Retained Earnings	-32.76	434.23	323.67	238.51	68.74	-300.86
Comprehensive Income & Other	-112.05	1.6	-	0.04	-	32.19
Shareholders' Equity	1,240	1,794	1,843	1,792	1,898	780.76
Total Liabilities & Equity	1,666	2,136	2,076	1,974	2,023	858.32
Total Debt	44.1	2.84	5.9	17.86	34.42	43.21
Net Cash (Debt)	239.34	935.33	1,329	1,252	1,309	371.77
Net Cash Growth	-62.68%	-29.63%	6.19%	-4.40%	252.17%	-33.40%
Net Cash Per Share	2.70	10.53	14.72	13.72	14.38	4.53
Filing Date Shares Outstanding	88.05	88.74	88.74	90.67	90.48	82.39
Total Common Shares Outstanding	88.05	88.74	88.74	90.67	90.48	82.39
Working Capital	149.24	894.16	1,289	1,292	1,370	438.31
Book Value Per Share	14.09	20.22	20.77	19.77	20.97	9.48
Tangible Book Value	1,227	1,784	1,832	1,780	1,887	770.86
Tangible Book Value Per Share	13.93	20.11	20.65	19.63	20.85	9.36
Machinery	-	93.5	91.2	85.39	82.64	104.52
Leasehold Improvements	-	63.28	65.23	65.23	63.9	63.64

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.